Cimeio Therapeutics

Basel, Switzerland

Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.

$50.0M raised

Apr 2022

Series A

Biopharma Biotechnology Health Care Medical

Top Investors

Versant Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cimeio Therapeutics

How much funding has Cimeio Therapeutics raised?

Cimeio Therapeutics has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in April 2022.

Who are Cimeio Therapeutics's investors?

Cimeio Therapeutics's investors include Versant Ventures.

Where is Cimeio Therapeutics headquartered?

Cimeio Therapeutics is headquartered in Basel, Switzerland.

What does Cimeio Therapeutics do?

Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.

What stage is Cimeio Therapeutics at?

Cimeio Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 13, 2022.

MLA

"Cimeio Therapeutics — Funding & Investors." VCBacked, April 13, 2022, https://www.vcbacked.co/company/cimeio-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Cimeio Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cimeio-therapeutics

Wikipedia (cite web)

{{cite web |title=Cimeio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cimeio-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 13, 2022.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.